key: cord-0803474-q0iw0xdi authors: Eriksen, Anne Zebitz; Møller, Rasmus; Markovoz, Bar; tenOever, Benjamin R.; Blenkinsop, Timothy A. title: Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids date: 2022-04-22 journal: STAR Protoc DOI: 10.1016/j.xpro.2022.101383 sha: 801be7491b0637202d0ac0f6204b0b95525c93c5 doc_id: 803474 cord_uid: q0iw0xdi Here, we describe a series of protocols detailing the steps for evaluating SARS-CoV-2 infection in models of the human eye. Included are protocols for whole eye organoid differentiation, SARS-CoV-2 infection, and processing organoids for single-cell RNA sequencing. Additional protocols describe how to dissect and culture adult human ocular cells from cadaver donor eyes and how to compare infection of SARS-CoV-2 and the presence of SARS-CoV-2 entry factors using qPCR, immunofluorescence, and plaque assays. For the adult human cells, cells are freshly isolated from post-mortem donor globes or from cornea donor shells rejected for use as transplants. Tissue should be isolated in preservation solution within 12h of death and processed for cell culture within 40h. Shorter time intervals between tissue isolation and processing will result in a higher yield of viable cells. Before obtaining human tissue, make sure your lab follows the institutional guidelines on how to handle and dispose of biohazardous materials and that consent forms from the donor or donor's family are in place. Before beginning work with infectious agents such as SARS-CoV-2, be sure the required licenses and safety protocols are in place for your lab. Beware (Zhang et al., 2020) Primer: TMPRSS2 Forward: GTCCCCACTGTCTACGAGGT (Vidal et al. 2015 ) (Vidal et al., 2015) Primer: TMPRSS2 Reverse: ATTGATACGGCTCCGGGACA (Vidal et al. 2015 ) (Vidal et al., 2015) Software Step-by-step method details Timing: 31-54days 1. Passage ESC to seed out colonies for SEAM differentiation, Day -8. a. Coat the desired number of wells of a 6-well plate with a 1:80 dilution of Matrigel in DMEM on ice. Use 1-1.5 mL of coating solution in each well and leave the plate to coat for 2h at 15-25°C or at least 1h in the incubator at 37°C. Keep the Matrigel solution cold until it is distributed in the well plate to avoid gelling. Agitate the plate side to side and front to back to get and even coating. b. Prepare 2 mL mTeSR media per well of a 6-well plate to be seeded and add 0.2 µL/mL of Thiazovivin stock solution. c. To passage the feeder-free H9 ESCs, begin by warming 0.5 mM EDTA to 37°C in a dry bath. d. Wash one well of a 6-well plate containing 80% confluent feeder-free ESCs with 1 mL of EDTA. e. Add 1 ml of EDTA and incubate for 2-3 min. f. Carefully aspirate the EDTA and add 1 mL of the prepared mTeSR media containing Thiazovivin. Agitate the plate to lift cells into suspension. Carefully wash the well with the cell suspension while maintaining cell aggregates (avoid breaking into single cells). g. Take a 10 µL sample from the cell suspension and mix it with 10 µL Trypan Blue, by vigorous trituration to break up cell clusters. h. Count the cells using a hemocytometer. J o u r n a l P r e -p r o o f i. Transfer a volume corresponding to 5000 cells/well to be seeded to the prepared mTeSR media. Triturate gently to ensure a homogeneous cell density without breaking the colonies down to single cells. j. Aspirate the coating solution and seed the cells in the Matrigel-coated wells. Distribute the aggregates by agitating the plate side to side and front to back. k. Incubate the cells for eight days at 37°C, changing the media every 1-3 days. Colonies should be 1-2 mm in diameter (see Figure 1A ) and be well-separated before initiating differentiation. The colonies should be sparse with good space between individual colonies >50 colonies/well to avoid colonies merging before zone 3. See Figure 1B for colonies after 1 week of differentiation. Note: Stem cells should be karyotyped every 10-15 passages, to test for chromosomal duplications, insertions, deletions, and translocations that can impact the differentiation of the cells. CRITICAL: When the culture matures and becomes confluent, extracellular matrix starts forming and some cultures will tend to lift from the plate. Be careful when moving the plate and feeding the cells; avoid agitating the plate to lift cells and collapse the culture (see Problem 1 under Trouble shooting). Timing: 3-4 weeks 5. Coat four wells of a 24-well plate per donor tissue type to be cultured with Synthemax-II-SC according to the manufacturer guidelines. 6. Prepare one 15 mL centrifuge tube for every tissue type to be processed, except retinal pigment epithelium (RPE), with 3 mL 2.5 mg/mL collagenase II, 0.6 µL thiazovivin (40nM) and 9 µL DNase 1 (1µU/mL), and heat to 37°C. 7. Prepare 5 mL trypsin EDTA with 40 nM thiazovivin and 3 µL/mL DNase 1 and heat to 37°C. 8. Prepare 30 mL TAB 2 media with 10 % additional hi-FBS and 40 nM thiazovivin and heat to 37°C. 9. If receiving a whole globe, sterilize the globe by submersion in a 30% solution of betadine and then rinsing with sterile PBS twice, before proceeding to dissection under sterile conditions. If receiving a cornea rejected for transplant proceed directly to dissection (step 10 b). 10. Isolation of sclera, cornea, and limbus a. Separate the anterior parts of the eye from the posterior part, by making a pars planar circular cut roughly 2 mm posterior to the limbus ( Figure 2A) . b. Make a circular cut separating the sclera from the limbus and cornea ( Figure 2B Left) and place the scleral tissue in a clean petri dish with sterile PBS to prevent tissue from drying out. c. Make a circular cut separating the limbus from the clear tissue of the cornea ( Figure 2B middle) and place the limbus and cornea into separate clean petri dishes with sterile PBS to prevent tissue from drying out. d. Aspirate the PBS. e. Cut the different tissues in to small pieces using a scalpel or a pair of scissors. f. Transfer the tissue pieces to the prepared tubes containing collagenase 2 solution. Close The lids loosely to allow gas exchange and incubate at 37°C in the incubator for 2 h, triturating with a p1000 pipette after 1 h of incubation. g. Add 300 µL hi-FBS to each tube and triturate with a p1000 pipette to mix. h. Pellet the cells by centrifugation at 300xg for 5min. i. Aspirate the supernatant and resuspend cells in 2 mL TAB2 media with 10% FBS and 40 nM thiazovivin. The cell suspension is divided into four wells of a Synthemax-II-SC coated 24-well plate, 500 µL/well. j. Incubate cells at 37°C in the incubator 5% CO2, 20% O2. 11. Isolation of iris a. Cut the ciliary marginal zone from the choroid at the top of the globe, like how the cornea and limbus were separated from the globe in step 10. Transferer the iris and ciliary marginal zone into a clean petri dish with sterile PBS to prevent tissue from drying. b. Separate the iris from the ciliary marginal zone by grabbing the iris with an angled pair of tweezers and the ciliary marginal zone with a pair of blunt tweezers, see Figure 2 E, and pull the tissues from each other. c. Place the iris in a clean petri dish. d. Cut the tissue into small pieces using a scalpel or a pair of scissors. e. Transfer the tissue pieces into the prepared tube containing collagenase 2 solution. Close The lid loosely to allow gas exchange and incubate at 37°C in the incubator for 2 h, triturating with a p1000 pipette after 1 h of incubation. f. Add 300 µL hi-FBS to the tube and triturate with a p1000 pipette to mix. J o u r n a l P r e -p r o o f g. Pellet the cells by centrifugation at 300xg for 5min. h. Aspirate the supernatant and resuspend cells in 2 mL TAB2 media with 10% FBS and 40 nM thiazovivin. The cell suspension is divided into four wells of a Synthemax-II-SC coated 24-well plate, 500 µL/well. i. Incubate cells at 37°C in the incubator 5% CO2, 20% O2. 12. Isolation of RPE a. Carefully fix the choroid to the sclera by insertion of 3 to 4 equally spaced 27-gauge needles around the opening of the globe. b. Lift out the lens and vitreous. If the retina is not attached to the vitreous, carefully detach the retina from the underlying pigmented cell layer and discard (See Problem 2 under Troubleshooting if retina does not detach). c. Add approximately 3 mL warm trypsin with 40 nM thiazovivin and 3 µL/mL DNase 1 is carefully, filling to globe to roughly 1 mm below the rim of the choroid-RPE ( Figure 2C ). d. Incubate the globe for 45min. e. Carefully detach the RPE cells from the choroid by gentle agitation with a sterilized brush ( Figure 2C ). Pigmentation in the trypsin should be clearly noticeable when removing the solution from the eye cup and placing it into media. f. Transfer the suspension to a centrifuge tube and add 1/10 of the total volume (roughly 300 µL) hi-FBS to inactivate the trypsin. g. Pellet the cells by centrifugation at 300xg for 5min. h. Aspirate the supernatant and gently resuspend the cells in 2 mL TAB2 media with 10% FBS and 40 nM thiazovivin. The cell suspension is divided into four wells of a Synthemax-II-SC coated 24-well plate, 500 µL/well. i. Incubate cells at 37°C in the incubator. 13. Isolation of choroid a. Gently wash the choroid with sterile PBS to limit RPE contamination. b. Peel the choroid from the globe with the blunt tweezers ( Figure 2D ) and transfer to a clean petri dish. c. Cut the tissue in to small pieces using a scalpel or a pair of scissors. d. Transfer the tissue pieces to the prepared tube containing collagenase 2 solution. Close the lid loosely to allow gas exchange and incubate at 37°C in the incubator for 2 h, triturating with a p1000 pipette after 1 h of incubation. e. Add 300 µL hi-FBS to the tube and triturate with a p1000 pipette to mix. f. Pellet the cells by centrifugation at 300xg for 5min. g. Aspirate the supernatant and resuspend cells in 2 mL TAB2 media with 10% FBS and 40 nM thiazovivin. The cell suspension is divided into four wells of a Synthemax-II-SC coated 24-well plate, 500µL/well. h. Incubate cells at 37°C in the incubator 5% CO2, 20% O2. (See Problem 3 under Troubleshooting) Note: When cells are confluent, they can be used for experiments or be further expanded by lifting with trypsin and replating onto Synthemax-II-SC coated plates. All cell types are passaged as described below. 14. Expansion of cells a. Aspirate the media and wash cells once with Ca 2+ -and Mg 2+ -free PBS. b. Add 0.5mL trypsin to each well to be lifted. Incubate cells with trypsin until they round-up and processes are visibly detaching. c. Inactivate the trypsin by adding 0.5 mL 10% hi-FBS in PBS to each well. d. Agitate plate to lift cells and transfer cells to a 15 mL centrifuge tube and pellet cells by centrifugation, at 300xg for 5 min. e. Aspirate supernatant and resuspend cells in TAB2 with 10% hi-FBS and 40 nM thiazovivin and replate cells 1:4 in Synthemax-II-SC coated plates. f. Incubate cells at 37°C in the incubator 5% CO2, 20% O2. Note: Cells should be used at low passage numbers (1-4) to avoid morphological and phenotypic changes. Cell identity can be verified with tissue type specific antibody stains, shown in Figure 8 . RPE cells should have cobble stone morphology and pigmentation. Scleral cells will be elongated, and cornea and limbus cells will look like fibroblast cells with patches for cobblestone morphology. Timing: 24 h This protocol describes how to inoculate SEAM-cultures with SARS-CoV-2 and maintain the cultures during infection. The same approach is applied when inoculating adult donor cells. When inoculating adult donor cells, serum-reduced SEAM media is swopped for TAB2 media, start at step 16. 15. Prepare 50 mL serum reduced SEAM media a. Mix 47mL GMEM with 1 mL knock out serum replacement, 0.5 mL GlutaMax, 0.5 mL non-essential amino acids, 0.5 mL penicillin-streptomycin solution, 0.5 mL sodium pyruvate and 19.2 µL β-mercaptoethanol stock (143mM) to give a final concentration of 55 µM. b. Filter the media through a 0.2 µm sterile filter and store at 4°C until use, use within 1 month. Note: Infections must be performed in media with maximum 2% serum. For infection of adult donor cells, infections should be carried out in TAB2-media. TAB2-media has 2% serum as standard and can be used directly. 16. Warm the serum-reduced SEAM-media to 37°C in a dry bath. 17. In the biosafety cabinet, prepare virus inoculum by diluting SARS-CoV-2 virus stock to 1 M.O.I. in 500 µL SEAM-media per 6-well to be infected. 18. In the biosafety cabinet, aspirate the media from the SEAM culture and replace with the prepared SARS-CoV-2 inoculum. In control wells, replace the media with serum reduced SEAM media without SARS-CoV-2. A. All work with SARS-CoV-2 virus must be carried out in a biosafety level 3 facility. When handling the virus, follow all CDC and institutionally approved guidelines. All waste material must be inactivated in an approved disinfectant and autoclaved before discarding. This protocol describes how to stain infected cells in 12-well plates, to evaluate infection and expression of the SARS-CoV-2 entry factor ACE2. The protocol can be used for cell type identifying markers and in SEAM cultures as well. 22. Fix cells with 4% PFA. a. Aspirate the media from the infected cells and control cells. b. Wash cells 3 times with 1 mL/well PBS. c. Remove PBS and add 1 mL of ice cold 4% PFA in PBS to each well. Seal the plate with parafilm and fix for a sufficient amount of time, following a protocol approved by your institution to ensure that the virus is completely inactivated, for our institution this is 24 h, at 4 °C. 23. Aspirate the PFA solution and wash the cells 3 times with 1 mL/well PBS. a. Block for unspecific antibody binding. i. Prepare blocking buffer, (See Materials and equipment section). ii. Aspirate PBS and add 0.5 mL blocking buffer to each well. Leave cells to block for 1 h on a bench rocker at 15-25°C. b. Add primary antibodies i. Prepare staining buffer. ii. Prepare dilutions of primary antibodies in staining buffer, 0.25 mL/well; mouse anti-SARS-CoV-2 (1:100), rabbit anti-ACE2(1:100). iii. Aspirate blocking buffer and incubate cells with primary antibodies on bench rocker at 4°C 12-18 h. c. Wash and add secondary antibodies. i. Aspirate the buffer and wash the cell by adding 0.25 mL/well fresh staining buffer and incubate on bench rocker for 5 min at 15-25°C. Repeat for a total of 3 washes. ii. Prepare secondary antibodies diluted in staining buffer, 0.25 ml/well, goatanti-mouse Alexa Fluor-488 (1.1000) and goat-anti-rabbit Alexa Fluor-647 (1:500), lastly add the nuclear stain, DAPI (1:1000). iii. After the last wash, aspirate the buffer and add 0.25 mL staining buffer with secondary antibody stains to each well. Incubate for 1 h on bench rocker at 15-25°C. Protect the plate from light to avoid bleaching of the fluorophores from this step onwards. iv. Aspirate the buffer and wash 3 x 5 min with PBS. d. After the final wash step, add PBS to cover cells. If proceeding directly to imaging, add minimal volume of PBS to cover cells for improved contrast in bright field images. Optional: For better, high-resolution imaging, SEAM cultures, and cells intended for immunohistochemical investigation, can be grown on glass bottom plates or cover slips. Pause point: Stained cells can be stored in sealed plates at 4°C for up to two months. When storing cells, add PBS to prevent the plate from drying and 0.1 % Na-azide to prevent bacterial growth. f. Triturate the cells using a p1000 pipette, and incubate for an additional 30 min at 37°C. Optional: If cells are not dissociating and large clumps are visible, add 0.5 mL fresh digestion buffer and incubate for an additional 30min. g. Triturate using a p1000 pipette the cell to break clumps down to single cells, transfer the cell suspension to a 15 mL centrifuge tube, and pellet the cells by spinning at 300xg for 5 min. h. Aspirate the supernatant and resuspend the pellet in 2 mL preservation media and filter the suspension through a 40 µm cell strainer. i. Count the cells and viability using a hemocytometer and Trypan Blue. Only if there is >10,000 cells and the viability is >80% continue to single-cell library preparation. j. Preparation of single-cell library according to the manufacturer's instructions (Cat. No: CG000331 Rev C, 10 Genomics ). Data analysis can be performed in R using the Seurat package (Stuart et al., 2019) . A code workflow is available on NBCI GEO GSE165477. The subgenomic RNAs of SARS-CoV-2 all have unique 5' ends but share the same 3' end. Hence, it is crucial to use a library prep kit that is based on 5' capture of transcripts such as Chromium Next GEM Single Cell 5' Kit v2 (10X, cat no. RN-10000265) in order to be able to distinguish between viral gene transcripts (Cohen et al., 2021) . Note: The 10X protocol provides several possible pause points so that library preparation can be split up over several days if needed. Plaque assays are performed to show that a viral infection is productive and that there is true replication of the virus in the infected cells. Here we describe how to perform a plaque assay on infected SEAM cultures to show productive infection in the eye organoids; however, plaque assays can be carried out on any cell type grown and infected in vitro. The plaque assay protocol is also used to titer the concentration of infectious virus used for infection experiments. 30. Seed Vero E6 cells at 400,000 cells/well in a 12 well plate and incubate cells at 37°C 5% CO2 12-18 h. 31. From the infected SEAM cultures, take 1 mL of the used media from each well and transfer to a clean 1.5 mL tube, Figure 4A . 32. Spin the samples for 5min at 300xg to pellet any cells and transfer the supernatant to a clean 1.5 mL tube, Figure 4B . 33. Make a logarithmic dilution series of the conditioned media samples. a. To make a 10 -1 X sample, take 100 µL conditioned media and dilute it with 900 µL Modified DMEM, Figure 4C . b. To make a 10 -2 X sample, take 100 µL of the 10 -1 X sample and dilute it with 900 µL Modified DMEM. c. Continue as described above until a dilution of 10 -6 . 34. Inoculate the Vero E6 using conditioned media samples. a. Aspirate the media and replace with 900 µL modified DMEM. b. Add 100 µL diluted infected sample media in each well. J o u r n a l P r e -p r o o f c. Allow virus adsorption by incubating for 1 h at 37°C 5% CO2, agitating the plate every 10 mins. a. Aspirate the inoculation media. b. Add 1 mL/well overlay media, Figure 4D . c. Incubate for 48-60 hours at 37°C 5% CO2. Note: Make overlay media with oxoid agar fresh every time. 36. Fix the plates by adding 1 mL/well 4% PFA and incubate for a sufficient amount of time to ensure complete inactivation of infectious virus approved by your institution. 37. Remove the fixative and stain each well by adding 1 mL/well crystal violet solution in 20% ethanol and incubate for 15 min at 15-25°C. 38. Aspirate the staining solution and determine viral titers (PFU/mL) by counting white colonies of dead cells in each sample, Figure 4E (see Problem 5 under Troubleshooting). Following the differentiation protocol for SEAM organoids adapted from the original publication from Hayashi et al. (Hayashi et al. 2016) , we obtain successful SEAM organoids with nice zone formation (see Figure 1C -F) in 90% of wells were differentiations are initiated. Mature SEAM cultures will have obvious zone formation, with round centers (zone 1) surrounded by a clearly pigmented zone (zone 2) ( Figure 5) . The Zones will have distinct protein expression patterns with markers related to cell fate specification ( Figure 6 ). Single cell RNA sequencing analysis of mature SEAM cultures result in a UMAPs where most of the major cell types of the eye can be recognized in the separated clusters, see Figure 7 . Infection yields of SEAM cultures using SARS-CoV2 virus was 100% (5 out of 5), and no visible signs of severe cell death in the organoid cultures were observed for at least until 72h post infection. Adult ocular cells isolated from donor eye globes consistently form confluent monolayers, however proliferation potential is highly dependent on the quality, and time between death to isolation. The resulting cell types will have different morphologies and have different expression of identifying specific cell type markers (See Figure 8 ). The protocols described here outline how to grow both primary adult ocular cells isolated from donor eye globes, and SEAM eye organoids that simultaneously represent all major cell types of the eye and evaluate infections and infectability with SARS-CoV-2 in these in vitro models. The protocol enables the side-by-side comparison of infectability between adult primary cells while also validating results from a stem cell-derived whole eye organoid model. Using these models in tandem enables greater confidence in overlapping results. Moreover, the stem cell-derived SEAM culture offers an examination of the interrelationships between developing cell fates resembling in vivo dynamics. However, an in vitro model will never be able to truly represent the complexity of the human eye. It should be noted that the SEAM cultures consist of maturing cells, and cells are still not fully mature at day 55. For instance, we do not see high expression of the corneal specific cytokeratins, keratin 3 and keratin 12 in the SEAM corneal cells even though other cornea markers are present. Further maturation of corneal cells can be obtained by following the original protocol by Hayashi et al.(Hayashi et al., 2016) , however this method requires the removal of zone 1 and 2 and limits the diversity of cell types that can be tested simultaneously. Another option could be using spheroid organoid culture systems that show better maturation of corneal cells. This approach, however, increases the complexity of the method and might also limit the variety of cell types present in the organoids. Additionally, worth mentioning is this study only used the H9 embryonic stem cell line. Therefore, infections of SEAM were only performed on that one genetic background. We have successfully differentiated SEAM organoids from other stem cell lines, including human induced pluripotent stem cells (iPSCs). While the infection has not been confirmed in iPSC derived SEAMs, successful differentiation into SEAM organoids and demonstration of cellular diversity has been confirmed. When performing an infection experiment, it is important to consider the accessibility of the different cell types in the model compared to the native organ. To that effect, it is important to note that the SEAM organoid grows primarily in 2 dimensions. Therefore, viral accessibility is equal between all cell types, and a more accurate representation of a cell's innate ability to become infected is revealed. However, context should be kept in mind and though a cell type can become infected, whether that cell type would become infected in a real-life scenario, is an open question. Additional factors including exposure time, viral titer and viral accessibility must be considered. For example, the ocular surface (cornea, limbus and sclera) is directly exposed to infectious agents in the air while the retina, RPE and iris are protected. Finally, an important aspect not recapitulated by the SEAM culture is the tear film turn over that acts as a first line defense in the eye, although we do see some expression of mucosal proteins in the limbus cells in the SEAM. Problem 1: Generation of SEAM Organoids, step 4. SEAM cultures can detach from the culture plate when they mature for over 60 days. Detaching can lead to contraction and collapse of the culture due to expression muscle proteins (Figure 9 ). If noticing the culture beginning to detach in the edge of the well, as depicted in Figure 9A , be extra careful when changing the media and moving the plate, to avoid collapse ( Figure 9B ). Problem 2: Isolation and culture of adult human ocular cells, step 12b. Retina does not separate from RPE-Choroid membrane. Potential solution: First soak the eye-cup in calcium and magnesium-free PBS for 5 minutes. This should loosen the bond between the retina and RPE layer. Next, pinch the RPE/Choroid tissue with a forcep in your nondominant hand. With either a paint brush or angled forcep in the dominant hand, gently scrape the retina in a downward motion to separate a small area of retina from the RPE/choroid tissue. Once a small area is separated, pinch the retina at that area and gently pull down to enlarge the separation. Rotate the globe and repeat. Eventually the whole retina will be separated and folded inside of the eye cup. This whole procedure must be done with the most delicate touch in order not to tear the tissue. Problem 5: Plaque Assay, Step 38 Unexpected cell-type tropism of SARS-CoV-2, attenuated growth in primary cells, changes in viral behavior or larger than normal plaques when performing plaque assays. Potential solution: When passaged on Vero E6 cells, SARS-CoV-2 may eliminate a naturally existing furin cleavage site in the spike protein at amino acid positions 681-685 (PRRAR) (Johnson et al., 2021) . The same low passage viral stock should be used for all experiments from which the results are to be compared. Before starting experiments, the presence of the furin cleavage site should be confirmed, either by Sanger sequencing of a PCR product that spans the site or by high-throughput sequencing of the entire viral genome. Lead contact J o u r n a l P r e -p r o o f Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Timothy A. Blenkinsop (timothy.blenkinsop@mssm.edu). This study did not generate any new unique reagents. The generated single cell RNAseq data sets are available through the National Center for Biotechnology Step-by-step illustration from when the shells are received until the initial plating and medium change. A) Circumferential incision 3-4 mm posterior to the ora serrata. B) Separating cornea, limbus, sclera and ciliary body/iris using small scissors, cutting individual pieces 1mm 2 , and placing pieces into separate tubes containing collagenase solution. C) For the retinal pigment epithelium, remove the retina and add 0.25% trypsin for 45-50 mins at 37 o C, 5%CO 2 , 20%O 2 . Using a sterile nylon paint brush, brush RPE of from the Bruch's membrane and collect in a conical tube. E) Separate the iris from the ciliary body using forceps, cut into small pieces and place into collagenase solution. , and PAX3 can be found sporadically in zone 3. Another eye field transcription factor LHX2 is strongly expressed by the neuroectoderm derived cells found in zone 2. Scale bar = 300 µm. Figure 7 : Annotated UMAP of two integrated scRNA-sequencing data sets from one healthy SEAM culture and one SEAM culture infected with SARS-CoV-2, as presented in (Eriksen et. al., 2021) . Highlights. • Identification of SARS-CoV-2 entry factors in cultured donor eye cells • Revealing cell types vulnerable to SARS-CoV-2 infection in whole eye organoid • Determination on of infection potential of SARS-CoV-2 in ocular cells • Protocol enables comparison of infection in donor cells and hESC-derived organoids eTOC Ocular entry by SARS-CoV-2 is a potential route of infection and models are needed to better not only understand infection progression, but also test potential therapeutics that mitigates disease. Here we describe human ocular cell models developed to study SARS-CoV-2 entry and infection with the goal of making these model systems more accessible for interested scientists. Classifications: Microbiology; Immunology; Health Sciences Imbalanced host response to SARS-CoV-2 drives development of COVID-19 Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing (preprint SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium Co-ordinated ocular development from human iPS cells and recovery of corneal function' Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis Fast gapped-read alignment with Bowtie 2' Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Comprehensive integration of single-cell data A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer Package "ggplot2"', Create Elegant Data Visualisations Using the Grammar of Graphics. Version Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro We would like to extend our gratitude to the patients and their families for their generous donations, as well as the Eye Bank for Sight Restoration for their support and work with processing donations. We would like to thank the Lundbeck foundation, R322-2019-2611, the Carlsberg Foundation, a Challenge Grant award from Research to Prevent Blindness, the National Eye Institute (NEI), and extramural grants 1R21EY030215-01, 1R01EY029736-01A1 and Icahn School of Medicine at Mount Sinai for supporting this work. None of the authors has any conflicts of interest to disclose.